| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ca2fe5a1e9022aa0323cbb48d30f5e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-04 |
| filingDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f28e4c39dda5055eeecaa5c2d59d5b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ddb1c6e1703c734dab0e13aceefe32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602328e1c2ac8320484821c848bf63f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473d1c81c1474bd99d381c6cc2e882a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25642beb42f870431a2f3ef4b5de229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9345840b70e6c9e60fac09a3c4db2f86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7606c57e3cfdcaf8256a387b23077101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85d1fc9bd263a2571b1b7a70855167d |
| publicationDate |
2009-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2049505-A2 |
| titleOfInvention |
Isoform-selective hdac inhibitors |
| abstract |
One aspect of the invention relates to isoform-selective HDAC inhibitors. Also provided are methods of sensitizing a cancer cell to the cytotoxic effects of radiotherapy. The invention also provides methods for treating cancer, methods for treating neurological diseases and methods for treating malaria. Additionally, the invention provides pharmaceutical compositions comprising an HDAC inhibitor of the invention; and kits comprising a an HDAC inhibitor of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013169858-A1 |
| priorityDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |